An application made for this job — a tailored resume and cover letter that speak straight to the posting.
National University Of Singapore is seeking an experienced clinical monitor to oversee study monitoring in the ADVANCE ID initiative. This project aims to improve public health by developing clinical evidence for combating drug-resistant infections.
The role includes conducting various site visits, ensuring adherence to protocols, and managing patient recruitment strategies while maintaining compliance with regulatory requirements. Ideal candidates will have relevant academic qualifications and experience in clinical research.
We are looking for an experienced clinical monitor to perform the study monitoring in the ADVANcing Clinical Evidence in Infectious Diseases Network (ADVANCE ID). ADVANCE ID is jointly funded by the Welcome Trust and Singapore institutions including the Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine, National University of Singapore. The vision of the Network is to improve public health by developing the clinical evidence base for the prevention and treatment of drug-resistant infections. Its mission is to build and sustain a strategic clinical research network focused on most efficiently delivering locally relevant interventions for drug-resistant infections.
The Network aims to improve and strengthen clinical research capabilities in the region by acting as a platform to develop good principles and practices. It will stabilise capacity and capabilities to mitigate inefficiencies in trial start-up phase and loss of skillset following study closure, as in typical trial setup. The Network will continuously develop its capabilities, quality and efficiency by learning from and collaborating with other clinical trial networks.
In the long term, the Network aims to support broader infectious disease studies by expanding geographically beyond its original starting point in South East Asia and collaborating with other networks around the world. It will function as an active network that involves patients in platform trials, allowing for rapid clinical research response in the event of an emerging infectious disease or pandemic threat.
The monitor should be able to supervise study sites and activities to ensure adherence to appropriate study protocols and applicable regulatory requirement terms of the study.